Changqing Su

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Klebsiella Pneumoniae

Breast Cancer Cells

Top Venues

Bioengineering (Basel, Switzerland)

Liver international : official journal of the International Association for the Study of the Liver

Genes to cells : devoted to molecular & cellular mechanisms

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Lin Ang, Jiang Li, Hui Dong, Chunhong Wang, Jin Huang, Mingcong Li, Min Zhao, Changqing Su, Qiang Wu
Chimeric Oncolytic Adenovirus Armed Chemokine Rantes for Treatment of Breast Cancer. Bioengineering (Basel, Switzerland) 9 (8) (2022)
Yinghan Su, Jiang Li, Weidan Ji, Gang Wang, Lin Fang, Qin Zhang, Lin Ang, Min Zhao, Yuan Sen, Lei Chen, Junnian Zheng, Changqing Su, Lunxiu Qin
Triple-serotype chimeric oncolytic adenovirus exerts multiple synergistic mechanisms against solid tumors. Journal for immunotherapy of cancer 10 (5) (2022)
Bin Sun, Weidan Ji, Chunying Liu, Xuejing Lin, Lei Chen, Haihua Qian, Changqing Su
miR-2392 functions as tumour suppressor and inhibits malignant progression of hepatocellular carcinoma via directly targeting JAG2. Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Lu Wu, Bin Sun, Xuejing Lin, Chunying Liu, Haihua Qian, Lei Chen, Yefa Yang, Feng Shen, Changqing Su
I131 reinforces antitumor activity of metuximab by reversing epithelial-mesenchymal transition via VEGFR-2 signaling in hepatocellular carcinoma. Genes to cells : devoted to molecular & cellular mechanisms 23 (1) (2017)